News & Spotlights, NNE-CTR, Larner College of Medicine, UVM

News Bits ...

Call for Proposals: 2024 Health Equity Summit

Discover and share exciting initiatives at the third annual Health Equity Summit, Building Solidarity: Sustainable Pathways Towards Health Equity. The Summit is a collaboration between community members, healthcare providers and educators to dismantle institutional barriers to health and enhance patient experiences.

Details

Dates: Monday, October 7, 4 - 6 pm: Poster presentations and kickoff reception

Tuesday, October 8, 8 am - 5 pm: Workshops and sessions

Location: Double Tree Hotel, 870 Williston Road, South Burlington, VT 05403 (Google Maps)

Sponsors: The 3rd Annual Health Equity Summit is a joint effort presented by the University of Vermont Health Network, the Larner College of Medicine, the College of Nursing and Health Sciences, and the University of Vermont.

More information: Health Equity Summit | The University of Vermont Health Network (uvmhealth.org)

Questions? Please email HESummit@uvmhealth.org

Recent News

For University of Vermont-related news, see below. For MaineHealth news, click here.

Kirkpatrick and Colleagues’ Study Reveals Effective, Single-Dose Dengue Vaccine

July 22, 2016 by Jennifer Nachbur

Researchers at the University of Vermont (UVM) Vaccine Testing Center, along with collaborators at the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health and Johns Hopkins Bloomberg School of Public Health, have been working since 2008 to develop a dengue vaccine that will protect against all four dengue strains.
Rincon and Thornton Discover a New Mechanism to Protect Cells in Response to DNA Breaks

July 22, 2016 by Carolyn Shapiro

Are we genetically doomed when the double helix we all identify with DNA breaks? No, say a team of researchers led by University of Vermont (UVM) immunologists, who discovered a novel mechanism that provides life support to cells while DNA double-strand break repairs are in progress.
Dostmann and Colleagues Discover Potential New Therapeutic Target for Hypertension, Earn Patent

July 22, 2016 by Jennifer Nachbur

A team of Vermont investigators has been issued a patent for their discovery of a molecule that rescues damaged blood vessels, yet preserves healthy vessels and could serve as a springboard for a new pharmaceutical therapy with fewer side effects for hypertension – a major risk factor for cardiovascular and kidney disease that effects roughly one in three people in the U.S.
Vaccine Testing Center Receives Funding to Advance New Treatments for Parasitic Infection

July 22, 2016 by Jennifer Nachbur

Limited treatment options and no vaccines exist to treat or prevent a leading cause of severe diarrhea in infants and young children in the developing world: Cryptosporidium, a single-celled intestinal parasite found in soil, food and water that also causes significant illness and death in immunocompromised individuals.
Morielli Shares Goals as New Director of UVM Neuroscience Graduate Program

July 22, 2016 by Carolyn Shapiro

To neuroscientist Anthony Morielli, Ph.D., the study of the brain opens a window to better understand the way the world works. “The brain is the one thing in the universe that can reflect back on itself,” says Morielli, a University of Vermont associate professor of pharmacology, who was recently named director of UVM’s Neuroscience Graduate Program.

Want to be our next news story?

Have you started a cool new project? Published a paper? Won an award? We want to hear from you! Contact us to be highlighted on our website, in our newsletters, and/or in our press releases.